Antiplatelet Therapy

Jun 21, 2016 by in HEMATOLOGY Comments Off on Antiplatelet Therapy

Antiplatelet Therapy Carlo Patrono As reviewed in other chapters, platelet activation and aggregation play a key role in atherothrombosis.1 Antiplatelet drugs target enzymes or receptors involved in the platelet synthesis…

read more

New Antithrombotic Drugs

Jun 21, 2016 by in HEMATOLOGY Comments Off on New Antithrombotic Drugs

New Antithrombotic Drugs Jeffrey I. Weitz Peter L. Gross Currently available antithrombotic drugs include (a) antiplatelet agents, which inhibit platelet activation or aggregation, (b) anticoagulants, which attenuate fibrin formation, and…

read more

Coumarin-Induced Skin Necrosis and Venous Limb Gangrene

Jun 21, 2016 by in HEMATOLOGY Comments Off on Coumarin-Induced Skin Necrosis and Venous Limb Gangrene

Coumarin-Induced Skin Necrosis and Venous Limb Gangrene Theodore E. Warkentin Thrombotic events that result from coumarin administration are incongruous but well-documented complications of anticoagulant therapy. The key role of coumarin…

read more

Hemorrhagic Complications of Anticoagulation

Jun 21, 2016 by in HEMATOLOGY Comments Off on Hemorrhagic Complications of Anticoagulation

Hemorrhagic Complications of Anticoagulation Sam Schulman Mark A. Crowther Bleeding is the most common complication of anticoagulant therapy. The spectrum is from seemingly harmless subcutaneous ecchymoses, albeit cosmetically disturbing for…

read more

Myeloproliferative Neoplasms and Thrombohemorrhagic Complications

Jun 21, 2016 by in HEMATOLOGY Comments Off on Myeloproliferative Neoplasms and Thrombohemorrhagic Complications

Myeloproliferative Neoplasms and Thrombohemorrhagic Complications Ayalew Tefferi The term “myeloproliferative disorder” (MPD) was first introduced by Dameshek1 in 1951 to emphasize the clinicopathologic interrelationship between essential thrombocythemia (ET), polycythemia vera…

read more

The Antiphospholipid Syndrome

Jun 21, 2016 by in HEMATOLOGY Comments Off on The Antiphospholipid Syndrome

The Antiphospholipid Syndrome Jacob H. Rand Lucia R. Wolgast HISTORICAL BACKGROUND The antiphospholipid syndrome (APS) is an autoimmune thrombophilic condition that is defined by a constellation of clinical and laboratory…

read more
Get Clinical Tree app for offline access